These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2840621)
1. Quantitative analysis of factors in recurrence of hepatocellular carcinoma. Kanno T; Harihara S; Kinoshita H; Tamori A; Kim K; Kuroki T; Mizoguchi Y; Kobayashi K; Hirohashi K; Monna T Osaka City Med J; 1987 Dec; 33(2):121-35. PubMed ID: 2840621 [No Abstract] [Full Text] [Related]
2. Recurrent needle-tract metastases of hepatocellular carcinoma following fine-needle aspiration. Pavan C; Parisi A; Girelli D Intern Med J; 2007 Feb; 37(2):134-6. PubMed ID: 17229260 [No Abstract] [Full Text] [Related]
3. [Clinical evaluation of dynamic MRI in the re-diagnosis of therapeutic effect and recurrence after transcatheter arterial embolization for hepatocellular carcinoma]. Kuwata Y; Hirota S; Sugimoto K; Koshino T; Nishida Y; Tomita M; Matsumoto S; Sako M; Kono M Gan To Kagaku Ryoho; 1994 Jul; 21(8):1235-40. PubMed ID: 8031167 [TBL] [Abstract][Full Text] [Related]
4. Unusual presentation of recurrent hepatocellular carcinoma as obstructive jaundice 15 years after liver transplant. Camci C; Gurakar A; Kohli V; Sharma S; Jabbour N Exp Clin Transplant; 2007 Dec; 5(2):713-5. PubMed ID: 18194129 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of prognosis and recurrence of hepatocellular carcinoma treated from 1988 to 2002 at Department of Medicine III, Kyushu University Hospital]. Arimura E; Nakamuta M; Kotoh K; Morizono S; Fukutomi M; Ohta S; Enjoji M; Sakai H; Nawata H Fukuoka Igaku Zasshi; 2004 Aug; 95(8):195-200. PubMed ID: 15552961 [TBL] [Abstract][Full Text] [Related]
7. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT J Am Coll Surg; 2008 Jul; 207(1):20-9. PubMed ID: 18589357 [TBL] [Abstract][Full Text] [Related]
8. Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma. Marsh JW; Casavilla A; Iwatsuki S; Dvorchik I; Subotin M; Balan V; Rakela J; Subbotin V; Popechitelev EP Hepatology; 1997 Dec; 26(6):1689-91. PubMed ID: 9398022 [No Abstract] [Full Text] [Related]
9. [A case of metastatic cutaneous nodules of recurrent hepatocellular carcinoma]. Cho M; Choi CS; Seo GS; Kim TH; Choi SC; Yun KJ; Kim HC Korean J Hepatol; 2007 Jun; 13(2):234-8. PubMed ID: 17585197 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial. Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514 [TBL] [Abstract][Full Text] [Related]
11. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Cucchetti A; Piscaglia F; Caturelli E; Benvegnù L; Vivarelli M; Ercolani G; Cescon M; Ravaioli M; Grazi GL; Bolondi L; Pinna AD Ann Surg Oncol; 2009 Feb; 16(2):413-22. PubMed ID: 19034578 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features of early hepatocellular carcinoma. Yamasaki T; Kurokawa F; Kato A; Irie K; Yutoku K; Terai S; Matsuzaki Y; Yasunaga M; Okita K Hepatogastroenterology; 1996; 43(10):926-31. PubMed ID: 8884315 [TBL] [Abstract][Full Text] [Related]
13. [Scrutiny and management of a patient with hepatocarcinoma]. Mondragón Sánchez R; Echeverría Miranda CA; Gómez Gómez E Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():69-70. PubMed ID: 17471865 [No Abstract] [Full Text] [Related]
14. Predictors and patterns of recurrence after resection of hepatocellular carcinoma. Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409 [TBL] [Abstract][Full Text] [Related]
15. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma. Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459 [TBL] [Abstract][Full Text] [Related]
16. The state of recurrence and the role of hepatectomy in hepatocellular carcinoma. Hashimoto T; Nakayama S; Fukkuhara T; Okuno T; Takamine Y; Konishi Y; Tani T; Kajiwara T Hepatogastroenterology; 1994 Apr; 41(2):144-9. PubMed ID: 8056402 [TBL] [Abstract][Full Text] [Related]
17. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. Shimozawa N; Hanazaki K J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736 [TBL] [Abstract][Full Text] [Related]
18. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy. Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841 [TBL] [Abstract][Full Text] [Related]
19. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation. Kubo S; Kinoshita H; Hirohashi K; Tanaka H; Tsukamoto T; Hamba H; Shuto T; Yamamoto T; Ikebe T; Wakasa K Hepatogastroenterology; 1999; 46(30):3212-5. PubMed ID: 10626188 [TBL] [Abstract][Full Text] [Related]